Product correctly added to cart.

discount label
Dihydroartemisinin (mixture of alpha and beta isomers)
View 3D

Biosynth logo

Dihydroartemisinin (mixture of alpha and beta isomers)

CAS: 131175-87-6

Ref. 3D-GFA17587

2g
59.00 €
5g
94.00 €
10g
130.00 €
25g
187.00 €
Estimated delivery in United States, on Thursday 30 May 2024

Product Information

Name:
Dihydroartemisinin (mixture of alpha and beta isomers)
Description:

Dihydroartemisinin is a drug that is used to treat malaria. It is a mixture of αlpha and β-isomers. It has been shown to be cytotoxic in vitro and in vivo, with significant cytotoxicity against cancer cells as well as minimal toxicity for non-cancer cells. Dihydroartemisinin also has significant activity against infectious diseases, including malaria and tuberculosis. Dihydroartemisinin (mixture of αlpha and beta isomers) Dihydroartemisinin (mixture of αlpha and beta isomers) belongs to the class of drugs called anti-malarial agents. It has been shown to be cytotoxic in vitro and in vivo, with significant cytotoxicity against cancer cells as well as minimal toxicity for non-cancer cells. Dihydroartemisinin also has significant activity against infectious diseases, including malaria and tuberculosis.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
284.35 g/mol
Formula:
C15H24O5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-GFA17587 Dihydroartemisinin (mixture of alpha and beta isomers)

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".